Perioperative treatment with enfortumab vedotin (EV) plus pembrolizumab has demonstrated a high pathological complete response (pCR) rate in patients with cisplatin‐ineligible muscle‐invasive bladder cancer (MIBC). However, whether this therapeutic benefit reflects true pharmacologic synergy or can be explained by inde...
Riko Ikeda, Soichiro Yoshida, Wei Chen et al.· International journal of uro...· 0 citations
Spectral computed tomography (CT) has become an important extension of contrast-enhanced CT (CECT) in oncologic imaging by providing material-specific information beyond conventional morphologic assessment. Dual-energy CT (DECT), implemented on energy-integrating detector CT (EID-CT) platforms, has demonstrated the val...
Yusuke Kawasaki, Kota Yokoyama, Hiroto Hada et al.· Insights into Imaging· 0 citations
Abstract Background Augmented reality (AR) glasses with waveguide optics and facial recognition may enhance patient identification and clinical workflows. However, their usability among physicians has not yet been evaluated. Objective The objective of this study was to assess the usability and acceptability of prototyp...
R. A. Ogasawara, Soichiro Yoshida, Kentaro Okamoto et al.· JMIR Human Factors· 0 citations
Circulating tumor DNA (ctDNA) increasingly guides adjuvant therapy and surveillance in urothelial carcinoma (UC), yet whether its prognostic effect is adequately summarized by a single pooled hazard ratio (HR), which assumes proportional hazards (PH), has not been formally evaluated. We searched five sources for studie...
S. Yajima, G. Okumura, Soichiro Yoshida et al.· Critical reviews in oncology...· 0 citations
This review summarizes the deep-learning architectures, fusion strategies, representative applications, and implementation challenges of mpMRI-centered multimodal AI.
M. Fujiwara, Soichiro Yoshida, Imon Banerjee et al.· Abdominal Radiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
